Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Galectin Therapeutics Inc. (GALT)

2.84   -0.04 (-1.39%) 01-24 16:00
Open: 2.86 Pre. Close: 2.88
High: 2.8903 Low: 2.81
Volume: 144,510 Market Cap: 162M
Galectin Therapeutics Inc is a clinical stage biopharmaceutical company. The Company is engaged in drug research and development to create new therapies for fibrotic disease and cancer.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.894 - 2.908 2.908 - 2.922
Low: 2.769 - 2.786 2.786 - 2.804
Close: 2.807 - 2.835 2.835 - 2.863

Technical analysis

as of: 2020-01-24 4:32:07 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 3.47     One year: 3.66
Support: Support1: 2.72    Support2: 2.26
Resistance: Resistance1: 2.97    Resistance2: 3.13
Pivot: 2.89
Moving Average: MA(5): 2.90     MA(20): 2.89
MA(100): 3.41     MA(250): 3.94
MACD: MACD(12,26): -0.04     Signal(9): -0.05
Stochastic oscillator: %K(14,3): 32.90     %D(3): 42.28
RSI: RSI(14): 43.35
52-week: High: 6.06  Low: 2.72  Change(%): -40.7
Average Vol(K): 3-Month: 26891  10-Days: 18375

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
GALT has closed above bottom band by 21.0%. Bollinger Bands are 70.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to GALT's normal range. The bands have been in this narrow range for 20 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 11 Nov 2019 18:39:03 +0000
Health Care Sector Update for 11/11/2019: GALT,NKTR,LPCN

Mon, 11 Nov 2019 20:31:55 +0000
Health Care Sector Update for 11/11/2019: MYOK,GALT,NKTR,LPCN

Tue, 29 May 2018 14:24:22 +0000
5 Clinical-Stage Biotech Stocks to Buy Under $10

Wed, 09 Oct 2019 19:21:01 +0000
Notable Wednesday Option Activity: ATVI, GALT, CLW

Wed, 09 Oct 2019 14:03:14 +0000
Analysts See 22% Gains Ahead For The Holdings of VTWO

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 56.78
Shares Float (M) 41.33
% Held by Insiders 28.47
% Held by Institutions 16.60
Shares Short (K) 4350
Shares Short P. Month (K)

Stock Financials

EPS -0.353
Book Value (p.s.) 0.830
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -22.9
Return on Equity (ttm) -38.3
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -9.10
Levered Free Cash Flow (M) -4.87

Stock Valuations

P/E -8.05
P/E Growth Ratio -0.01
P/BV 3.42
P/CF -17.72

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2012-03-22
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.